PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for February 27, 2007 Subscribe to this News Feed    
 

University Lab Technologies Begins Production of ARTHROLEVE ULT(TM) and ZENSTRAL PMS(TM)

BOCA RATON, Fla. (Business Wire EON/PRWEB ) February 27, 2007 -- University Lab Technologies announced today the start of production of its two revolutionary, patent pending product formulations Arthroleve ULT(TM) and Zenstral PMS(TM).

Today's announcement marks a milestone in the company's commitment to its rapid timeline for both its development and to market strategies.

Arthroleve ULT is a revolutionary, patent pending nutraceutical formulation which contains clinically proven ingredients for the treatment of arthritis, fibromyalgia, and non-specific lower back pain (NSLBP). In addition, it is delivered in a pharmaceutical grade caplet which utilizes ULT's advanced Slick Cap Technology to optimize its absorption by the intestinal tract. Each Arthroleve caplet is packaged in foil blister packs to ensure quality. The market for Arthroleve includes more than 43 million U.S. adults who suffer from arthritis and chronic pain.

Zenstral PMS is an entirely unique, patent pending nutraceutical formulation which contains ingredients that are clinically proven for the treatment of both PMS and Premenstrual dysphoric disorder, a more severe form of PMS. Zenstral PMS is also delivered in pharmaceutical grade, foil blister packed caplets employing ULT's Slick Cap Technology. The target market for Zenstral PMS includes approximately 13-20 million women in the U.S. of reproductive age who suffer from PMS.

The company anticipates its first production run lasting between 6-8 weeks with both products being available to consumers as early as May 1, 2007. The company has and remains focused on its commitment to its timeline during every stage of its growth. Dr. Morrow, president and chief scientific officer of University Lab Technologies Inc., was quoted as saying, Our product development and production cycle timelines have been met on every target to date." Dr Morrow went on to say, We would like to thank both our employees and our shareholders for their continuing support and for sharing in the vision of University Lab Technologies.

About University Lab Technologies (http://www.universitylabtechnologies.com): Every year university labs around the globe identify, research and test natural compounds and formulations which have the potential to improve the quality of life of our lives.

Over 98% of these potentially life changing discoveries are never commercialized for the benefit of the public

University Lab Technologies, in collaboration with universities worldwide, researches and identifies those compounds that have proven evidence based effects and have the greatest potential for improving our lives.

University Lab Technologies' mission is the deliver the latest advances and discoveries in natural compounds packaged in our unique patented formulations and delivered to satisfy the needs of consumers for the treatment of many common chronic ailments. www.universitylabtechnologies.com

Optimized by Newsforce

See the original story at: http://eon.businesswire.com/releases/university_lab/lab_technologies/prweb507677.htm

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/RmFsdS1TaW5nLVByb2YtSG9yci1NYWduLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION

University Lab Technologies, Boca Raton
George Theodore, 800-517-7734

ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move